{"id":"NCT01541215","sponsor":"Novo Nordisk A/S","briefTitle":"Efficacy and Safety of Liraglutide in Combination With Metformin Compared to Metformin Alone, in Children and Adolescents With Type 2 Diabetes","officialTitle":"Efficacy and Safety of Liraglutide in Combination With Metformin Versus Metformin Monotherapy on Glycaemic Control in Children and Adolescents With Type 2 Diabetes","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2012-11-13","primaryCompletion":"2017-11-15","completion":"2020-05-20","firstPosted":"2012-02-29","resultsPosted":"2018-12-11","lastUpdate":"2021-07-02"},"enrollment":135,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Diabetes","Diabetes Mellitus, Type 2"],"interventions":[{"type":"DRUG","name":"liraglutide","otherNames":[]},{"type":"DRUG","name":"placebo","otherNames":[]},{"type":"DRUG","name":"metformin","otherNames":[]}],"arms":[{"label":"Lira + Met","type":"EXPERIMENTAL"},{"label":"Placebo + Met","type":"PLACEBO_COMPARATOR"}],"summary":"This trial is conducted globally. The aim of this trial is to assess the efficacy and safety of liraglutide in the paediatric population in order to potentially address the unmet need for treatment of children and adolescents with type 2 diabetes.","primaryOutcome":{"measure":"Change in HbA1c (Glycosylated Haemoglobin)","timeFrame":"Week 0, week 26","effectByArm":[{"arm":"Liraglutide 1.8 mg","deltaMin":-0.643,"sd":0.215},{"arm":"Placebo","deltaMin":0.415,"sd":0.216}],"pValues":[{"comp":"OG000 vs OG001","p":"<0.001"}]},"eligibility":{"minAge":"10 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":185,"countries":["United States","Australia","Austria","Belgium","Brazil","Canada","Croatia","Denmark","Egypt","France","Germany","Greece","Hungary","India","Israel","Italy","Lebanon","Malaysia","Mexico","Morocco","Netherlands","New Zealand","North Macedonia","Norway","Poland","Portugal","Puerto Rico","Romania","Russia","Serbia","Spain","Sweden","Taiwan","Thailand","Turkey (TÃ¼rkiye)","United Kingdom"]},"refs":{"pmids":["31034184","33634589"],"seeAlso":["http://novonordisk-trials.com"]},"adverseEventsSummary":{"seriousAny":{"events":9,"n":66},"commonTop":["Nasopharyngitis","Nausea","Headache","Diarrhoea","Vomiting"]}}